Act | West FY 23 Semi-Annual Report: October 2022 - March 2023
This report outlines the key achievements and challenges in the first six months of the fifth year of program implementation, spanning the period October 2022 - March 2023.
Act West FY 2023-SAR I-Oct 2022-Mar 2023.pdf
Type
Semi-annual report
Year of publication
Disease
All Preventive Chemotherapy NTDs
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
AIM Initiative, Deloitte, FHI360, HDI, Helen Keller International, World Vision